Journals / Journal of the Turkish-German Gynecological Association / 2014 / Cilt: 15 - Sayı: 2

Does bleeding affect fetal Doppler parameters during genetic amniocentesis?

Pages
100–103
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Bleeding during genetic amniocentesis did not change umbilical artery and middle cerebral artery Doppler parameters. (J Turk Ger Gynecol Assoc 2014; 15: 100-3) in

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the relationship between fetal Doppler parameters and bleeding at insertion points during amniocentesis.
📊
Key Findings & Data:Material and Methods: This prospective study was conducted between July 2010 and February 2011.
💡
Conclusion & Impact:Conclusion: Bleeding during genetic amniocentesis did not change umbilical artery and middle cerebral artery Doppler parameters. (J Turk Ger Gynecol Assoc 2014; 15: 100-3) in
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate the relationship between fetal Doppler parameters and bleeding at insertion points during amniocentesis. Material and Methods: This prospective study was conducted between July 2010 and February 2011. A total of 215 amniocentesis procedures were performed during this period. Five patients with Down syndrome were excluded from the study. The remaining 210 patients were divided into Group 1 (bleeding at insertion site) and Group 2 as a control group. One needle type was used for all patients. Umbilical artery resistance index (UARI), umbilical artery pulsatility index (UAPI), middle cerebral artery resistance index (MCARI), middle cerebral artery pulsatility index (MCA PI), and middle cerebral artery peak systolic velocity (MCAPSV) were measured immediately and before and after amniocentesis. Results: Bleeding at the insertion point during amniocentesis did not significantly change the UARI (34% increase for Group 1 and 46.5% in- crease for Group 2, p=0.238), the MCARI (52% increase for Group 1 and 45% increase for Group 2, p=0.622), or the MCAPSV (37% increase for Group 1 and 49% increase for Group 2, p=0.199). UARI, MCARI, MCA PI, and MCAPSV were not significantly altered following amniocentesisGroups 1 and 2. There was a significant increase in UAPI following amniocentesis only in Group 2. Conclusion: Bleeding during genetic amniocentesis did not change umbilical artery and middle cerebral artery Doppler parameters. (J Turk Ger Gynecol Assoc 2014; 15: 100-3) in

🔖

Cite This Article

KALAYCI, H., ÇOK, T., PARLAKGÜMÜŞ, A., YALÇINKAYA, C., TARIM, E., İSKENDER, C. (2022). Does bleeding affect fetal Doppler parameters during genetic amniocentesis?. Journal of the Turkish-German Gynecological Association, Cilt: 15 - Sayı: 2, 100–103. https://ajindex.com/articles/567590

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010
  2. [CrossRef] Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK. Risk factors for procedure-related fetal losses after mid- trimester genetic amniocentesis. Prenat Diagn 2006
  3. [CrossRef] Dacus JV, Wilroy RS, Summitt R, Garbaciak JA, Abdella TN, Spinnato JA. Genetic amniocentesis: a twelve years’ experience. Am J Med Genet 1985
  4. [CrossRef] Antsaklis A, Papantoniou N, Xygakis A, Mesogitis S, Tzortzis E, Michalas S. Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn 2000
  5. [CrossRef] Haugen G, Helbig A, Husby H. Umbilical artery Doppler flow veloc- ity waveforms after transplacental amniocentesis. Obstet Gynecol 2003
  6. [CrossRef] Martinez JP, Comas C, Ojuel J, Puerto B, Borrell A, Fortuny A. Doppler assessment of umbilical flow after genetic amniocentesis. Early Hum Dev 1996
  7. [CrossRef] Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986
  8. [CrossRef] Andreasen E, Kristoffersen K. Incidence of spontaneous abortion after amniocentesis: influence of placental localization and past obstetric and gynecologic history. Am J Perinatol 1989
  9. [CrossRef] Marthin T, Liedgren S, Hammar M. Transplacental needle passage and other risk-factors associated with second trimester amniocen- tesis. Acta Obstet Gynecol Scand 1997
  10. [CrossRef] Kalogiannidis I, Prapa S, Dagklis T, Karkanaki A, Petousis S, Prapas Y, Prapas N. Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis. Clin Exp Obstet Gynecol 2011
  11. Giorlandino C1, Mobili L, Bilancioni E, D’Alessio P, Carcioppolo O, Gentili P, Vizzone A. Transplacental amniocentesis: Is it really a higher-risk procedure? Prenat Diagn 1994
  12. [CrossRef] Athanasiadis AP, Pantazis K, Goulis DG, Chatzigeorgiou K, Vaitsi V, Assimakopoulos E, et al. Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications. Prenat Diagn 2009
  13. [CrossRef] Subira ́ D, Uriel M, Serrano C, Castan ̃o ́n S, Gonzalo R, Illa ́n J, et al. Significance of the volume of fetomaternal hemorrhage after performing prenatal invasive tests. Cyt